Letting PTSD patients choose method of treatment improves their health, quality of life: new research

August 16, 2018, Case Western Reserve University
PTSD
Regions of the brain associated with stress and posttraumatic stress disorder. Credit: National Institutes of Health

Letting people with post-traumatic stress disorder (PTSD) choose between treatment methods improves their quality of life and reduces the disorder's symptoms, according to new research from Case Western Reserve University.

The same data also showed that patients with PTSD using marijuana or other drugs saw poorer outcomes from treatment, mainly because they dropped out of treatment programs—potentially prolonging their cycle of PTSD and substance use.

"When patients receive proven PTSD treatments, their symptoms and quality of life improve," said Norah Feeny, the study's co-author and a professor of psychological studies at Case Western Reserve. "When patients choose their treatment, they're more likely to stick with it, helping the magnitude of their improvement."

The findings were based on a study of 200 patients with PTSD, a chronic and debilitating condition that affects up to 11 percent of the population nationally, according to previous peer-reviewed research. For this study, some patients were randomly assigned one of two treatments: exposure therapy or the medication sertraline (commonly known as Zoloft). Other patients received their preferred choice of the two treatments.

Exposure therapy includes having patients talk about their traumatic experiences and gradually confront avoidances that can negatively affect relationships, work and functioning. Patients in this study met with a therapist for 10 weekly sessions.

Substance abuse itself did not seem to influence the effectiveness of either treatment, but did substantially increase the risk of dropping or not adhering to treatment. Patients with PTSD are two to four times more likely to have a substance-use disorder than people without the condition, previous studies have shown.

"Clinically, this has implications," Feeny said. "Special emphasis can be placed on retaining these patients, perhaps by designing and emphasizing treatments that are brief and of low burden."

Among the new findings:

  • Patients who use or have a long history of using marijuana were almost twice as likely to drop out of both treatments;
  • Patients with a history of marijuana-use disorder were more likely see less improvement of their symptoms;
  • Of the two treatments, exposure therapy results in better health-related outcomes than setraline, especially in patients who prefer exposure; and
  • Patients with recent marijuana use and other drug-use showed less adherence to , but not to sertraline.

Researchers explored marijuana use in particular because of increasing rates of use as more states legalize the substance.

"Also, given the opioid crisis and an estimated 300,000 veterans from recent wars suffering from PTSD or major depression, these studies further our understanding about how to best treat each patient, especially those who may be more susceptible to substance use," Feeny said.

The research was published in two recent papers from the Optimizing PTSD Treatments study, led by Feeny and Lori A. Zoellner, of the University of Washington, and funded by the National Institutes of Mental Health since 2003.

The study "Alcohol, Cannabis, and Other Drug Use: Engagement and Outcome in PTSD Treatment" was published in the journal Psychology of Addictive Behaviors. Co-authors include Michele Bedard-Gilligan and Natalia Garcia, from the University of Washington.

The study "Effects of , choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD)" was published in the journal Quality of Life Research.

Explore further: Reducing severity of PTSD symptoms long-term holds significant public-health and economic implications

More information: Michele Bedard-Gilligan et al. Alcohol, cannabis, and other drug use: Engagement and outcome in PTSD treatment., Psychology of Addictive Behaviors (2018). DOI: 10.1037/adb0000355

Quang A. Le et al. Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD), Quality of Life Research (2018). DOI: 10.1007/s11136-018-1833-4

Related Stories

Reducing severity of PTSD symptoms long-term holds significant public-health and economic implications

April 6, 2018
Both civilians and military veterans with post-traumatic stress disorder (PTSD) reap long-term benefits from psychotherapies used for short-term treatment, according to a new study from Case Western Reserve University.

In cancer patients, PTSD may increase symptom burden

June 26, 2018
(HealthDay)—Post-traumatic stress disorder (PTSD) symptoms among hospitalized patients with cancer are associated with a greater psychological and physical symptom burden as well as a decreased risk of hospital readmissions, ...

Can just 5 therapy sessions work for those with PTSD?

January 30, 2018
(HealthDay)—A mere five sessions of specialized therapy could help people struggling from post-traumatic stress disorder (PTSD), new research suggests.

Patients with PTSD together with sleep apnea may have reduced quality of life

February 8, 2016
New research finds patients suffering from posttraumatic stress disorder (PTSD) and obstructive sleep apnea (OSA) experienced lower quality of life, more sleepiness, and less adherence and response to positive airway pressure ...

PTSD treatment cost-effective when patients given choice

May 28, 2014
A cost-analysis of post-traumatic stress disorder treatments shows that letting patients choose their course of treatment – either psychotherapy or medication – is less expensive than assigning a treatment and provides ...

Depression symptoms and emotional support impact PTSD treatment progress

January 23, 2014
Many individuals with posttraumatic stress disorder (PTSD) also experience depression. Researchers at Case Western Reserve University found that during PTSD treatments, rapid improvements in depression symptoms are associated ...

Recommended for you

Junk food diet raises depression risk, researchers find

December 18, 2018
A diet of fast food, cakes and processed meat increases your risk of depression, according to researchers at Manchester Metropolitan University.

Looking on bright side may reduce anxiety, especially when money is tight

December 17, 2018
Trying to find something good in a bad situation appears to be particularly effective in reducing anxiety the less money a person makes, possibly because people with low incomes have less control over their environment, according ...

Levels of gene-expression-regulating enzyme altered in brains of people with schizophrenia

December 14, 2018
A study using a PET scan tracer developed at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) has identified, for the first time, epigenetic differences between the brains of individuals ...

Self-perception and reality seem to line-up when it comes to judging our own personality

December 14, 2018
When it comes to self-assessment, new U of T research suggests that maybe we do have a pretty good handle on our own personalities after all.

Video game players frequently exposed to graphic content may see world differently

December 13, 2018
People who frequently play violent video games are more immune to disturbing images than non-players, a UNSW-led study into the phenomenon of emotion-induced blindness has shown.

Researchers discover abundant source for neuronal cells

December 13, 2018
USC researchers seeking a way to study genetic activity associated with psychiatric disorders have discovered an abundant source of human cells—the nose.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.